655
Views
10
CrossRef citations to date
0
Altmetric
Review

Advanced multimodal diagnostic approaches for detection of lung cancer

, , &
Pages 409-417 | Received 13 Feb 2019, Accepted 10 Apr 2019, Published online: 22 Apr 2019

References

  • Society AC. Cancer facts & figures 2018. Cancer Facts Fig. 2018;2018:1–71.
  • Midthun DE. Early detection of lung cancer. F1000 Res. 2016;2016:1-10.
  • Prabhakar B, Shende P, Augustine S. Current trends and emerging diagnostic techniques for lung cancer. Biomed Pharmacother. 2018;106:1586–1599.
  • Travis WD, Brambilla E, Nicholson AG, et al. The 2015 world health organization classification of lung tumors. J Thorac Oncol. 2015;10:1243.
  • Zamay TN, Zamay GS, Kolovskaya OS, et al. Current and prospective protein biomarkers of lung cancer. Cancers (Basel). 2017;9:1–22.
  • Shende P, Patel C. siRNA: an alternative treatment for diabetes and associated conditions. J Drug Target. 2018;27(2):1–36.
  • Seijo LM, Peled N, Ajona D, et al. Biomarkers in lung cancer screening: achievements, promises, and challenges. J Thorac Oncol. 2019;14(3):1–15.
  • Li P, Shi JX, Xing MT, et al. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer. Tumor Biol. 2017;39:1010428317711662.
  • Ajona D, Castaño Z, Garayoa M, et al. Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement. Cancer Res. 2004;64:6310.
  • Ajona D, Pajares MJ, Corrales L, et al. Investigation of complement activation product C4d as a diagnostic and prognostic biomarker for lung cancer. J Natl Cancer Inst. 2013;105:1385.
  • Elazezy M, Joosse SA. Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management. Comput Struct Biotechnol J. 2018;16:370–378.
  • Doseeva V, Colpitts T, Gao G, et al. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer. J Transl Med. 2015;13:55.
  • Belinsky SA, Liechty KC, Gentry FD, et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res. 2006;66:3338–3344.
  • Holz O, Sterk PJ, Djukanovic R, et al. Sputum induction. Eur Respir J. 2003;20:3s–8s.
  • Nightingale JA, Rogers DF, Barnes PJ. Effect of repeated sputum induction on cell counts in normal volunteers. Thorax. 1998;53:87–90.
  • Thunnissen FBJM. Sputum examination for early detection of lung cancer. J Clin Pathol. 2003;29(1):19–23.
  • Xie Y, Todd NW, Liu Z, et al. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer. 2010;67:170–176.
  • Xing L, Su J, Guarnera MA, et al. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules. Clin Cancer Res. 2015;21:484–489.
  • Su Y, Fang HB, Jiang F. Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection. Clin Epigenetics [Internet]. 2016;8:1–9.
  • Su J, Liao J, Gao L, et al. Analysis of small nucleolar RNAs in sputum for lung cancer diagnosis. Oncotarget [Internet]. 2015;7:5131–5142. Available from: http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article⊕view&path%5B%5D=4219&path%5B%5D=9352
  • Sozzi G, Conte D, Leon ME, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol. 2003;21:3902–3908.
  • Sandfeld-Paulsen B, Jakobsen KR, Bæk R. Exosomal proteins as diagnostic biomarkers in lung cancer. J Thorac Oncol. 2016;11:1701–1710.
  • Sherwood JL, Corcoran C, Brown H, et al. Optimised pre-analytical methods improve KRAS mutation detection in circulating tumour DNA (ctDNA) from patients with non-small cell lung cancer (NSCLC). PLoS One. 2016;11:1–14.
  • Horváth I, Barnes PJ, Loukides S, et al. A European respiratory society technical standard: exhaled biomarkers in lung disease. Eur Respir J. 2017;49(4):1600965.
  • Capuano R, Santonico M, Pennazza G, et al. The lung cancer breath signature: A comparative analysis of exhaled breath and air sampled from inside the lungs. Sci Rep [Internet]. 2015;5:1–10.
  • Corradi M, Poli D, Banda I, et al. Exhaled breath analysis in suspected cases of non-small-cell lung cancer: A cross-sectional study. J Breath Res [Internet]. 2015;9:27101.
  • Li M, Yang D, Brock G, et al. Breath carbonyl compounds as biomarkers of lung cancer. Lung Cancer. 2015;90:92–97.
  • Saalberg Y, Wolff M. VOC breath biomarkers in lung cancer. Clin Chim Acta. 2016;459:5–9.
  • Bikov A, Hernadi M, Korosi BZ, et al. Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer. BMC Pulm Med. 2014;14:202.
  • Shende P, Vaidya J, Kulkarni YA, et al. Systematic approaches for biodiagnostics using exhaled air. J Control Release [Internet]. 2017;268:282–295.
  • Wang W, Wang S, Zhang M. Identification of urine biomarkers associated with lung adenocarcinoma. Oncotarget. 2017;8:38517–38529.
  • Xia X, Su C-H, Zhang S-S, et al. Midkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer. Oncotarget. 2016;7:87462–87472.
  • Nolen BM, Lomakin A, Marrangoni A, et al. Urinary protein biomarkers in the early detection of lung cancer. Cancer Prev Res. 2015;8:111–119.
  • Ribaut C, Loyez M, Larrieu JC, et al. Cancer biomarker sensing using packaged plasmonic optical fiber gratings: towards in vivo diagnosis. Biosens Bioelectron. [Internet]. 2017;92:449–456.
  • Ligler F, Taitt C. Optical biosensors. Opt Biosens. 2008;60:91–100.
  • Chakravarty S, Lai WC, Zou Y, et al. Multiplexed specific label-free detection of NCI-H358 lung cancer cell line lysates with silicon based photonic crystal microcavity biosensors. Biosens Bioelectron [Internet]. 2013;43:50–55.
  • Chien PJ, Suzuki T, Tsujii M, et al. Bio-sniffer (gas-phase biosensor) with secondary alcohol dehydrogenase (S-ADH) for determination of isopropanol in exhaled air as a potential volatile biomarker. Biosens Bioelectron [Internet]. 2017;91:341–346.
  • Ribaut C, Voisin V, Malachovská V, et al. Small biomolecule immunosensing with plasmonic optical fiber grating sensor. Biosens Bioelectron. [Internet]. 2016;77:315–322.
  • Chiu NF, Lin TL, Kuo CT. Highly sensitive carboxyl-graphene oxide-based surface plasmon resonance immunosensor for the detection of lung cancer for cytokeratin 19 biomarker in human plasma. Sens Actuators B Chem [Internet]. 2018;265:264–272.
  • Deng H, Liu Q, Wang X, et al. Quantum dots-labeled strip biosensor for rapid and sensitive detection of microRNA based on target-recycled nonenzymatic amplification strategy. Biosens Bioelectron. 2017;87:931–940.
  • Weng XH, Xu XW, Wang CL, et al. Genotyping of common EGFR mutations in lung cancer patients by electrochemical biosensor. J Pharm Biomed Anal. 2018;150:176–182.
  • Chen Y, Huang X, Shi H, et al. A novel and cost-effective method for early lung cancer detection in immunized serum. Asian Pac J Cancer Prev. 2011;12:3009.
  • Eksin E, Bikkarolla SK, Erdem A, et al. Chitosan/nitrogen doped reduced graphene oxide modified biosensor for impedimetric detection of microRNA. Electroanalysis. 2018;30:551–560.
  • Hussain MA, Ansari TM, Gawas PS, et al. Lung cancer detection using artificial neural network & fuzzy clustering. IJARCCE. 2015;4:360–363.
  • Wang B, Cancilla JC, Torrecilla JS, et al. Artificial sensing intelligence with silicon nanowires for ultraselective detection in the gas phase. Nano Lett. 2014;14:933–938.
  • De Carvalho Filho AO, De Sampaio WB, Silva AC, et al. Automatic detection of solitary lung nodules using quality threshold clustering, genetic algorithm and diversity index. Artif Intell Med. 2014;60(3):165-177.
  • ITU. Measuring the information society report 2014. Int Commun Union. 2014.
  • Jin H, Huynh TP, Haick H. Self-healable sensors based nanoparticles for detecting physiological markers via skin and breath: toward disease prevention via wearable devices. Nano Lett. 2016;16:4194–4202.
  • Cannon C. Telehealth, mobile applications, and wearable devices are expanding cancer care beyond walls. Semin Oncol Nurs. 2018;34(2):1–8.
  • Cancer research UK. App launched to help doctors assess risk of lung cancer in people with lung nodules [Internet]. Press release. 2016. Available from: https://www.cancerresearchuk.org/about-us/cancer-news/press-release/2016-12-06-app-launched-to-help-doctors-assess-risk-of-lung-cancer-in-people-with-lung-nodules.
  • Shi J, Zhou M, Gong A, et al. Fluorescence lifetime imaging of nanoflares for mRNA detection in living cells. Anal Chem. 2016;84:2062–2066.
  • Nag S, Castro M, Choudhary V, et al. Sulfonated poly(ether ether ketone) [SPEEK] nanocomposites based on hybrid nanocarbons for the detection and discrimination of some lung cancer VOC biomarkers. J Mater Chem B. 2017;5:348–359.
  • Kim NH, Choi SJ, Yang DJ, et al. Highly sensitive and selective hydrogen sulfide and toluene sensors using Pd functionalized WO3nanofibers for potential diagnosis of halitosis and lung cancer. Sens Actuators B Chem. 2014;193:574–581.
  • Curtis ASG, Dolby M, Gadegaand N. Cell signaling arising from nanotopography: implications for nanomedical devices. Nanomedicine. 2006;67–72.
  • Wu Y, Wu H, Kuan C, et al. Multi-functionalized carbon dots as theranostic nanoagent for gene delivery in lung cancer therapy. Sci Rep [Internet]. 2016;1–12. DOI:10.1038/srep21170
  • Alberti D, Protti N, Toppino A, et al. A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment. Nanomed Nanotechnol Biol Med [Internet]. 2015;11:741–750.
  • Zamay GS, Kolovskaya OS, Zamay TN, et al. Aptamers selected to postoperative lung adenocarcinoma detect circulating tumor cells in human blood. Mol Ther [Internet]. 2015;23:1486–1496.
  • Wu Y, Zhang H, Xiang J, et al. Ultrasensitive and high specific detection of non-small-cell lung cancer cells in human serum and clinical pleural effusion by aptamer-based fluorescence spectroscopy. Talanta. 2018;179:501–506.
  • Zhao L, Tang C, Xu L, et al. Enhanced and differential capture of circulating tumor cells from lung cancer patients by microfluidic assays using aptamer cocktail. Small. 2016;12:1072–1081.
  • Farrington K, Vasapollo G, Sole RD, et al. Molecularly imprinted polymers: present and future prospective. Int J Mol Sci. 2011;12:5908–5945.
  • Johari-Ahar M, Karami P, Ghanei M, et al. Development of a molecularly imprinted polymer tailored on disposable screen-printed electrodes for dual detection of EGFR and VEGF using nano-liposomal amplification strategy. Biosens Bioelectron. 2018;107:26–33.
  • Deshmukh K, Tanwar YS, Shende P, et al. Biomimetic estimation of glucose using non-molecular and molecular imprinted polymer nanosponges. Int J Pharm. 2015;494:244–248.
  • Shim TS, Chi HS, Lee SD, et al. Adequately washed bronchoscope does not induce false-positive amplification tests on bronchial aspirates in the diagnosis of pulmonary tuberculosis. Chest. 2002;121:774–781.
  • Santarpia M, Liguori A, D’Aveni A, et al. Liquid biopsy for lung cancer early detection. J Thorac Dis. 2018;882–897.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.